从基因到生活方式:阿尔茨海默病预防和治疗的多维框架
1Department of Medical Laboratory, Hebei North University, Zhangjiakou, China.
Ageing research reviews
|November 21, 2025
概括
多omics集成揭示了关键基因和星细胞在阿尔茨海默病 (AD) 中的作用. 生活方式干预和药物重定向为阿尔茨海默病提供了新的精准医学策略,超越单个目标,采取整体方法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学 是一个学科.
背景情况:
- 阿尔茨海默氏症 (AD) 病原发生涉及复杂的,多层次的分子和细胞机制.
- 单一的方法不足以充分阐明AD的复杂途径.
- 大规模的多omics集成对于发现AD的遗传和表观遗传网络至关重要.
研究的目的:
- 对阿尔茨海默病的综合性多学科见解进行审查.
- 为了确定关键的基因,细胞机制,和治疗策略为AD.
- 倡导一个多维的精准医学框架,用于AD.
主要方法:
- 转录组学,表观组学 (甲基化) 和遗传关联研究 (GWAS,eQTL,mQTL) 的整合.
- 分析单细胞和空间转录组学以确定细胞类型特定的基因丰富.
- 使用DrugBank进行药物重用分析,以确定潜在的治疗候选者.
主要成果:
- 确定了KLHL21,SCN2B,ZNF415和PITRM1作为AD病变的潜在贡献者.
- 突出了星球细胞在阿尔茨海默病理学中的作用,特别是与已识别的基因相关.
- 证明运动调节关键的AD相关基因表达.
- 确定FDA批准的药物和天然化合物作为AD的潜在治疗剂.
结论:
- 精准医学框架整合遗传,细胞,网络和生活方式因素对于AD至关重要.
- 向"基因-细胞-网络-生活方式"范式的转变为AD治疗和预防提供了新的途径.
- 多学科方法提供了对AD的全面理解,使得有针对性和整体的治疗策略成为可能.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.药物 药物 药物 药物 药物运动运动运动.在 KLHL2121多个omics的多个omics.这就是PANoptosis.这就是PITRM1的原因.这就是SCN2B.在 ZNF41515 中.更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.3K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.3K
相关概念视频
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:28Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
01:30Dementia
498
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
498
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
01:30Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835